Nkarta, Inc. (NKTX)
2.59
-0.07
(-2.63%)
USD |
NASDAQ |
Aug 24, 16:00
2.59
0.00 (0.00%)
After-Hours: 20:00
Nkarta Debt to Equity Ratio : 0.2968 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2968 |
| March 31, 2026 | 0.2624 |
| December 31, 2025 | 0.2447 |
| September 30, 2025 | 0.2268 |
| June 30, 2025 | 0.2196 |
| March 31, 2025 | 0.2083 |
| December 31, 2024 | 0.1968 |
| September 30, 2024 | 0.1983 |
| June 30, 2024 | 0.1888 |
| March 31, 2024 | 0.184 |
| December 31, 2023 | 0.3232 |
| September 30, 2023 | 0.3014 |
| June 30, 2023 | 0.2846 |
| March 31, 2023 | 0.2634 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.2228 |
| September 30, 2022 | 0.2091 |
| June 30, 2022 | 0.1721 |
| March 31, 2022 | 0.3028 |
| December 31, 2021 | 0.0496 |
| September 30, 2021 | 0.0474 |
| June 30, 2021 | 0.044 |
| March 31, 2021 | 0.0406 |
| December 31, 2020 | 0.0278 |
| September 30, 2020 | 0.0273 |
| June 30, 2020 | -0.8139 |
| March 31, 2020 | 0.2745 |
| December 31, 2019 | -2.634 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ironwood Pharmaceuticals, Inc. | -2.452 |
| Theriva Biologics, Inc. | 0.2915 |
| Unicycive Therapeutics, Inc. | 0.0139 |
| OnKure Therapeutics, Inc. | 0.0054 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 337.64M |
| Total Liabilities (Quarterly) | 89.91M |
| Shareholders Equity (Quarterly) | 247.74M |
| Current Ratio | 7.981 |
| Net Debt Paydown Yield | 0.53% |